Regis Healthcare (REG) H2 2026 earnings summary

Executive summary

• Revenue from services rose 16% year-over-year to AUD 1.35 billion, with underlying EBITDA up 10% to AUD 138 million and underlying NPAT up 4% to AUD 55.6 million.

• Mature home occupancy reached 96%, with total occupied bed days up 8% to 2.85 million and net RAD cash inflow up 28% to AUD 250.5 million.

• Significant portfolio expansion through acquisitions (Rockpool and OC Health, 830 beds) and greenfield developments, with 1,300 beds in the pipeline.

• Strategic focus on digitisation, portfolio renewal, and disciplined growth, with new clinical management systems and digital catering platforms rolled out.

• Announced CFO transition, with Stuart Hooper to commence September 1.

Financial highlights

• Revenue from services increased 16% to AUD 1.35 billion, driven by acquisitions and demand trends.

• Underlying EBITDA rose 10% to AUD 138 million; statutory NPAT up 14% to AUD 55.7 million; operating cash flow up 10% to AUD 336.3 million.

• Net RAD cash inflows up 28% to AUD 250.5 million; CapEx rose to AUD 143.1 million, supporting growth and refurbishments.

• Final dividend of AUD 0.094 per share, 100% franked, up 16% year-over-year.

• Staff expenses increased 18.7% due to higher wages and mandated care minutes, now 78.1% of revenue.

Outlook and guidance

• Focus on growing resident-funded revenue, leveraging scale, and disciplined growth through acquisitions and developments.

• Confident in long-term sector fundamentals despite government funding lagging cost inflation.

• RAD retention earnings expected to exceed AUD 50 million per annum by FY 2029.

• CapEx for FY 2027 expected north of AUD 150 million, with emphasis on construction and refurbishments.

• Room repricing and demographic trends expected to drive future cash inflow and earnings.